Baird Oracle · ORCL

Baird Lowers Oracle Price Target to $200

Analyst: Rob Oliver 1 min read Reproduced verbatim
Rating
Outperform
Target
$200
from $300 (−33%)
Outcome
Reached
on May 28, 2026
Baird and Oracle logos

What the analyst said

Baird analyst Rob Oliver lowered the price target on Oracle (NYSE: ORCL) to $200.00 (from $300.00) while maintaining an Outperform rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $116. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $200 target is 14% below the median.

Since the note ORCL has moved −23% (from $152). 12-month window: day 241 of 365, closes on March 10, 2027.

Track record

This call✓ Target reached on May 28, 2026, 3 months after the note.

Firm track recordBaird: 90% of its 31 targets at least a year old were reached within 12 months (#1 of 26 firms). Accuracy ranking →

Baird on Oracle

Baird price targets on Oracle

3 calls from March 10, 2026 to October 29, 2026. The target went from $200 to $215 (+8%). The rating stayed Buy.

Baird targetORCL share price
  1. October 29, 2026Kept the $215 targetBuy$215
  2. June 11, 2026Target raised from $200 (+8%)Buy$215
  3. March 10, 2026 This noteEarliest call shownBuy$200
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained Citizens JMPBuy Kept rating and price target Oct 29 $285maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.